These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 491958)

  • 1. A kinetic analysis of plasma insulin disappearance and glucose-induced insulin delivery rate in diabetic and nondiabetic acromegalics.
    Maneschi F; Pilo A; Navalesi R
    Metabolism; 1979 Oct; 28(10):1011-22. PubMed ID: 491958
    [No Abstract]   [Full Text] [Related]  

  • 2. Nocturnal monitoring of growth hormone, insulin, C-peptide, and glucose in patients with acromegaly.
    Tsai JS; Zorrilla LL; Jacob KK; Rosenberg S; Marcus DL
    Am J Med Sci; 1996 Jun; 311(6):281-5. PubMed ID: 8659555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic bromocriptine treatment and glucose intolerance in acromegaly.
    Popović V; Micić D; Nesović M; Djordjević P; Mićić J; Djurić DS
    Exp Clin Endocrinol; 1985 Jun; 85(3):351-7. PubMed ID: 3899685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin secretion and glucose tolerance in acromegaly.
    Marek J; Páv J; Srámková J
    Endokrinologie; 1976; 68(3):300-8. PubMed ID: 1009908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin: diabetes and acromegaly.
    Gerich JE
    Adv Intern Med; 1977; 22():251-72. PubMed ID: 190870
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin and growth hormone responses to glucose loading in treated acromegalics.
    Akerblom HK; Newman PR; Meakin JW; Martin JM; Simpson WJ
    Diabetologia; 1969 Jun; 5(3):183-7. PubMed ID: 5373817
    [No Abstract]   [Full Text] [Related]  

  • 7. Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects.
    Bagdade JD; Bierman EL; Porte D
    Metabolism; 1971 Nov; 20(11):1000-7. PubMed ID: 5115750
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects.
    Cerasi E; Ependić S; Luft R
    Lancet; 1973 Apr; 1(7807):794-7. PubMed ID: 4121221
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early insulin response following intravenous glucose loading in acromegaly].
    Krassowski J
    Pol Tyg Lek; 1980 Mar; 35(9):301-4. PubMed ID: 6988823
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose-response study of the inhibiting effect of somatostatin on growth hormone and insulin secretion in normal subjects and acromegalic patients.
    Giustina G; Peracchi M; Reschini E; Panerai E; Pinto M
    Metabolism; 1975 Jul; 24(7):807-15. PubMed ID: 1138156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pancreatic beta-cell in the field of current diabetology].
    Schatz H
    Acta Med Austriaca; 1974; 3(1):79-88. PubMed ID: 4377060
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin-like and diabetogenic effects of growth hormone in healthy subjects, diabetics, and low insulin responders.
    Adamson U; Efendic S
    J Clin Endocrinol Metab; 1979 Sep; 49(3):456-61. PubMed ID: 468979
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum-insulin in acromegaly.
    Elkeles RS; Wright AD; Lowy C; Fraser TR
    Lancet; 1969 Sep; 2(7621):615-8. PubMed ID: 4185594
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P; Vague J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin resistance and insulin secretion in non-diabetic acromegalic patients.
    Coculescu M; Niculescu D; Lichiardopol R; Purice M
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):308-16. PubMed ID: 17516294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human growth hormone as a regulator of blood glucose concentration and as a diabetogenic substance.
    Luft R; Cerasi E
    Diabetologia; 1968 Jan; 4(1):1-9. PubMed ID: 5741523
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12.
    Byrne MM; Sturis J; Menzel S; Yamagata K; Fajans SS; Dronsfield MJ; Bain SC; Hattersley AT; Velho G; Froguel P; Bell GI; Polonsky KS
    Diabetes; 1996 Nov; 45(11):1503-10. PubMed ID: 8866553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the pathogenesis of diabetes in acromegaly.
    Luft R; Cerasi E; Hamberger CA
    Acta Endocrinol (Copenh); 1967 Dec; 56(4):593-607. PubMed ID: 5630505
    [No Abstract]   [Full Text] [Related]  

  • 19. [Test meals in normal subjects and in treated diabetics].
    Tchobroutsky G
    Presse Med (1893); 1970 Jun; 78(30):1359-64. PubMed ID: 5421552
    [No Abstract]   [Full Text] [Related]  

  • 20. Acromegaly: insensitivity of the pancreatic alpha cell to hyperglycaemia.
    Seino Y; Taminato T; Goto Y; Inoue Y; Kadowaki S; Mori K; Imura H
    Clin Endocrinol (Oxf); 1978 Dec; 9(6):577-81. PubMed ID: 371862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.